Lianbo Li

Dr. Lianbo Li

Departments of Biochemistry and Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2017 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
YYyan yang
yan yang
LDLili Ding
Lili Ding
QHQun Hu
Qun Hu
JXJia Xia
Jia Xia
JSJunjie Sun
Junjie Sun
ALAiguo Liu
Aiguo Liu
Aberrant expression of microRNAs in different human cancer types has been widely reported. MiR-218 acts as a tumor suppressor in diverse human cancer types impacting regulation of multiple genes in oncogenic pathways. Here, we evaluated the expression and function of miR-218 in human lung cancer and ALDH positive lung cancer cells to understand the potential mechanisms responsible for disease pathology. Also, the association between its host genes and the target genes could be useful towards the better understanding of prognosis in clinical settings. Publicly-available data from The Cancer Genome Atlas (TCGA) was mined to compare the levels of miR-218 and its host gene SLIT2/3 between lung cancer tissues and normal lung tissues. Transfection of miR-218 to investigate its function in lung cancer cells was done and in vivo effects were determined using miR-218 expressing lentiviruses. Aldefluor assay and Flow cytometry was used to quantify and enrich ALDH positive lung cancer cells. Levels of miR-218, IL-6R, JAK3 and phosphorylated STAT3 were compared in ALDH1A1 positive and ALDH1A1 negative cells. Overexpression of miR-218 in ALDH positive cells was carried to test the survival by tumorsphere culture. Finally, utilizing TCGA data we studied the association of target genes of miR-218 with the prognosis of lung cancer. We observed that the expression of miR-218 was significantly down-regulated in lung cancer tissues compared to normal lung tissues. Overexpression of miR-218 decreased cell proliferation, invasion, colony formation, and tumor sphere formation in vitro and repressed tumor growth in vivo. We further found that miR-218 negatively regulated IL-6 receptor and JAK3 gene expression by directly targeting the 3′-UTR of their mRNAs. In addition, the levels of both miR-218 host genes and the components of IL-6/STAT3 pathway correlated with prognosis of lung cancer patients. MiR-218 acts as a tumor suppressor in lung cancer via IL-6/STAT3 signaling pathway regulation.

1 August 2017 in Cell Chemical Biology
Verified
Journal Article
Closed access
MZMei Zeng
Mei Zeng
JLJia Lu
Jia Lu
Lianbo LiLianbo Li
Lianbo Li
FFFrederic Feru
Frederic Feru
CQChunshan Quan
Chunshan Quan
NGNathanael S. Gray
Nathanael S. Gray

6 April 2020 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
FFFleur M. Ferguson
Fleur M. Ferguson
BNBehnam Nabet
Behnam Nabet
SRSrivatsan Raghavan
Srivatsan Raghavan
YLYan Liu
Yan Liu
ALAlan L. Leggett
Alan L. Leggett
NGNathanael S. Gray
Nathanael S. Gray

1 January 2017 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
WHWayne Harshbarger
Wayne Harshbarger
SGSudershan Gondi
Sudershan Gondi
SFScott B. Ficarro
Scott B. Ficarro
JHJohn Hunter
John Hunter
DUDurga Udayakumar
Durga Udayakumar
Kenneth WestoverKenneth Westover
Kenneth Westover
Glutathione S-transferase pi 1 (GSTP1) is frequently overexpressed in cancerous tumors and is a putative target of the plant compound piperlongumine (PL), which contains two reactive olefins and inhibits proliferation in cancer cells but not normal cells. PL exposure of cancer cells results in increased reactive oxygen species and decreased GSH. These data in tandem with other information led to the conclusion that PL inhibits GSTP1, which forms covalent bonds between GSH and various electrophilic compounds, through covalent adduct formation at the C7-C8 olefin of PL, whereas the C2-C3 olefin of PL was postulated to react with GSH. However, direct evidence for this mechanism has been lacking. To investigate, we solved the X-ray crystal structure of GSTP1 bound to PL and GSH at 1.1 Å resolution to rationalize previously reported structure activity relationship studies. Surprisingly, the structure showed that a hydrolysis product of PL (hPL) was conjugated to glutathione at the C7-C8 olefin, and this complex was bound to the active site of GSTP1; no covalent bond formation between hPL and GSTP1 was observed. Mass spectrometry (MS) analysis of the reactions between PL and GSTP1 confirmed that PL does not label GSTP1. Moreover, MS data also indicated that nucleophilic attack on PL at the C2-C3 olefin led to PL hydrolysis. Although hPL inhibits GSTP1 enzymatic activity in vitro, treatment of cells susceptible to PL with hPL did not have significant anti-proliferative effects, suggesting that hPL is not membrane-permeable. Altogether, our data suggest a model wherein PL is a prodrug whose intracellular hydrolysis initiates the formation of the hPL-GSH conjugate, which blocks the active site of and inhibits GSTP1 and thereby cancer cell proliferation.

8 October 2021 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
VMVenkatesh P. Mysore
Venkatesh P. Mysore
ZZZhi-Wei Zhou
Zhi-Wei Zhou
Chiara AmbrogioChiara Ambrogio
Chiara Ambrogio
Lianbo LiLianbo Li
Lianbo Li
JKJonas N. Kapp
Jonas N. Kapp
DSDavid E. Shaw
David E. Shaw

30 November 2016 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
YXYuan Xiong
Yuan Xiong
JLJia Lu
Jia Lu
JHJohn Hunter
John Hunter
Lianbo LiLianbo Li
Lianbo Li
DSDavid Scott
David Scott
NGNathanael S. Gray
Nathanael S. Gray